GSK Plc (GSK)
51.17
-0.08
(-0.16%)
USD |
NYSE |
Jun 10, 16:00
51.18
+0.02
(+0.03%)
After-Hours: 20:00
GSK EPS Diluted (TTM) : 3.824 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.824 |
| December 31, 2025 | 3.664 |
| September 30, 2025 | 3.506 |
| June 30, 2025 | 2.145 |
| March 31, 2025 | 1.926 |
| December 31, 2024 | 1.582 |
| September 30, 2024 | 1.537 |
| June 30, 2024 | 2.475 |
| March 31, 2024 | 2.750 |
| December 31, 2023 | 2.992 |
| September 30, 2023 | 3.638 |
| June 30, 2023 | 8.964 |
| March 31, 2023 | 8.488 |
| December 31, 2022 | 8.790 |
| September 30, 2022 | 8.555 |
| June 30, 2022 | 3.122 |
| March 31, 2022 | 3.570 |
| December 31, 2021 | 3.116 |
| September 30, 2021 | 2.937 |
| June 30, 2021 | 2.940 |
| March 31, 2021 | 3.373 |
| December 31, 2020 | 3.636 |
| September 30, 2020 | 4.025 |
| June 30, 2020 | 4.183 |
| March 31, 2020 | 3.406 |
| Date | Value |
|---|---|
| December 31, 2019 | 2.951 |
| September 30, 2019 | 2.904 |
| June 30, 2019 | 2.878 |
| March 31, 2019 | 2.560 |
| December 31, 2018 | 2.403 |
| September 30, 2018 | 1.246 |
| June 30, 2018 | 1.122 |
| March 31, 2018 | 0.7009 |
| December 31, 2017 | 0.9745 |
| September 30, 2017 | 1.507 |
| June 30, 2017 | 1.243 |
| March 31, 2017 | 1.042 |
| December 31, 2016 | 0.588 |
| September 30, 2016 | 0.1506 |
| June 30, 2016 | 0.0322 |
| March 31, 2016 | 0.4712 |
| December 31, 2015 | 6.550 |
| September 30, 2015 | 7.670 |
| June 30, 2015 | 7.586 |
| March 31, 2015 | 8.034 |
| December 31, 2014 | 2.319 |
| September 30, 2014 | 3.534 |
| June 30, 2014 | 3.958 |
| March 31, 2014 | 4.205 |
| December 31, 2013 | 4.395 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AstraZeneca PLC | 3.330 |
| Johnson & Johnson | 8.649 |
| Eli Lilly & Co. | 27.78 |
| Merck & Co., Inc. | 3.553 |
| Novo Nordisk A/S | 4.261 |